Proteona Pte. Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Proteona Pte. Ltd. - overview
Established
2017
Location
Singapore, -, Singapore
Primary Industry
Biotechnology
About
Based in Singapore, and established in 2017, Proteona Pte. Ltd. , is a biomedical company that provides single-cell analysis services for its customers. The company is a result of a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology, and Research (A*STAR).
Jonathan Scolnick, Gene Yeo, and Shawn Hoon are the co-founders of the firm, and in March 2022, Xingeyuan Biotechnology Co. , Ltd. acquired the firm. As of April 2022, Proteona Pte.
Ltd. is being led by its CEO, Andreas Schmidt, and has operations in Singapore, Germany, and the US. The company offers clinical sample analysis services through its proprietary platform called ESCAPE™ (enhanced single-cell analysis with protein expression), enabling pharmaceutical firms, clinicians, etc to add single-cell level precision to their projects, and thereby enhance the clinical outcomes. The firm’s platform generates both genomic and proteomic data from a single cell, identifies various biomarkers, and creates ML (Machine Learning) based models that predict therapeutic response and disease severity.
Additionally, Proteona Pte. Ltd. provides AI (Artificial Intelligence) and bioinformatics-powered single-cell data analysis for its customers.
Current Investors
Xingeyuan Biotechnology Co., Ltd., Pix Vine Capital, SEEDS Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Software
Website
www.proteona.com
Verticals
Artificial Intelligence
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Proteona Pte. Ltd. - timeline of key events
Proteona Pte. Ltd. - financials
| Fiscal Year Ended | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|
| Revenue (USD) | 154,970 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | (2,446,968) | - | - | - |
| Operating Income (USD) | (2,701,132) | - | - | - |
| Operating Margin | (1743.0%) | - | - | - |
| % EBITDA Margin | (1579.0%) | - | - | - |
| NET Income (USD) | (2,711,856) | - | - | - |
| % Net Margin | (1749.9%) | - | - | - |
Proteona Pte. Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.